fda approves first oral glp-1 obesity drug august 1 2025 Novo's Wegovy Inches Closer to Becoming FDA-Approved Weight-Loss Pill US FDA Approves Wegovy Pill
Description
GLP-1 Oral Solution by Peak Now offers a needle-free, quick-absorbing option for weight loss

danuglipron, which has completed Phase II studies demonstrating significant reductions in blood sugar and body weight
He stopped taking it which made him seriously ill and put his life at risk

Pulmonary embolisms and deep vein thrombosis (DVT), which are blood clot conditions potentially linked to semaglutide

[DOI] [PMC free article] [PubMed] [Google Scholar] 234.Petersen A.B., Knop F.K., Christensen M
